RxDoctor Payments Data

James Charles

Internal Medicine · Rock Hill, SCNPI 1962405316

Payments from drug & device makers

$7,741in general payments, 2019–2025

Across 513 payments — averaging $15.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Viiv Healthcare Company$3K
  • Gilead$3K
  • AbbVie$685
  • Johnson & Johnson$268
  • Merck$191
  • Napo Pharmaceuticals Inc$161
  • plus $550 from 11 others

What the payments were for

  • Speaking & faculty fees$621%
  • Food & beverage$7,40796%
  • Education$2724%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$7,741 in reported general payments places this provider in the 90th percentile of 1,498 internal medicine providers in South Carolina.

See all internal medicine providers in South Carolina

Most prescribed under Part D

DrugClaimsCost to plans & patients
BiktarvyBictegrav/Emtricit/Tenofov Ala745$2,868,038
SymtuzaDarunavir/Cob/Emtri/Tenof Alaf160$720,675
TriumeqAbacavir/Dolutegravir/Lamivudi174$616,440
OdefseyEmtricitab/Rilpiviri/Tenof Ala165$574,542
DovatoDolutegravir Sodium/Lamivudine188$551,511
JulucaDolutegravir/Rilpivirine141$466,562
TivicayDolutegravir Sodium103$284,126
DescovyEmtricitabine/Tenofov Alafenam91$196,548
RukobiaFostemsavir Tromethamine23$187,161
GenvoyaElviteg/Cob/Emtri/Tenof Alafen38$143,775
PrezcobixDarunavir/Cobicistat43$96,227
Isentress HdRaltegravir Potassium46$84,644
IsentressRaltegravir Potassium24$45,138
Efavirenz-Emtric-Tenofov DisopEfavirenz/Emtricit/Tenofovr Df20$32,653
EdurantRilpivirine Hcl23$31,715

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GileadBiktarvy, Descovy, Genvoya$2,667$3,208,361874 claims
Viiv Healthcare CompanyTriumeq, Dovato, Juluca, Tivicay, Rukobia$3,220$2,105,800629 claims
Janssen Products, LPSymtuza$159$720,675160 claims
MerckIsentress Hd, Isentress, Pifeltro$191$159,56287 claims
Johnson & JohnsonPrezcobix, Xarelto$268$102,63055 claims
PfizerEliquis$15$13,22623 claims
AbbVieLinzess$685$10,12217 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,498 internal medicine providers in South Carolina.

Other internal medicine in Rock Hill

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →